Why We Invested
The Somatus story is one of those rare moments when a variety of factors aligned – Key regulatory change, a team of domain experts that intimately understood an archaic industry, a handful of early adopter customers, and a group of patient investors. Ikenna Okezie and Tony Welters as co-founders have continued to navigate strong market headwinds to improve the lives of hundreds of thousands of patients managing kidney disease and in the process reducing healthcare costs and improving quality outcomes.
Somatus partners with nephrology and primary care groups, leading health plans, and health systems to provide integrated care for patients with, or at risk of developing, kidney disease. As the market leader in value-based kidney care, Somatus’ vertically integrated clinical services and technologies delay or prevent disease progression, improve quality and care coordination, and increase the use of home dialysis modalities and rates of kidney transplantation.